Roles of microRNA-330 and Its Target Gene ING4 in the Development of Aggressive Phenotype in Hepatocellular Carcinoma Cells
Authors:
- 3 January 2017
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 62 (3) , 715-722
Abstract
Aberrant expression of microRNAs contributes to tumor growth and progression.Keywords
This publication has 25 references indexed in Scilit:
- Adenovirus-mediated co-expression of ING4 and PTEN cooperatively enhances their antitumor activity in human hepatocellular carcinoma cellsActa Biochimica et Biophysica Sinica, 2016
- OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in CancerCancer Research, 2016
- MicroRNAs and oncogenic transcriptional regulatory networks controlling metabolic reprogramming in cancersComputational and Structural Biotechnology Journal, 2016
- Synergistic tumor suppression by adenovirus-mediated ING4/PTEN double gene therapy for gastric cancerCancer Gene Therapy, 2015
- miR-34: from bench to bedsideOncotarget, 2014
- Mir-184 Post-Transcriptionally Regulates SOX7 Expression and Promotes Cell Proliferation in Human Hepatocellular CarcinomaPLOS ONE, 2014
- Adenovirus-mediated ING4 Gene Transfer in Osteosarcoma Suppresses Tumor Growth via Induction of Apoptosis and Inhibition of Tumor AngiogenesisTechnology in Cancer Research & Treatment, 2014
- MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylationOncogene, 2009
- Decreased Expression of Inhibitor of Growth 4 Correlated with Poor Prognosis of Hepatocellular CarcinomaCancer Epidemiology, Biomarkers & Prevention, 2009
- The inhibitor of growth (ING) gene family: potential role in cancer therapy.Current Cancer Drug Targets, 2008